Dr. Reddy’s arm Aurigene Oncology gets DCGI nod for Phase 2 trial for CAR-T cell therapy for multiple myeloma
Dr. Reddy's subsidiary Aurigene Oncology receives approval for Phase 2 trial of novel CAR-T cell therapy for myeloma.
8 Oct 18:08 · The Hindu